VivoSight Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 11

VivoSight General Information

Description

Developer of an optical coherence tomography skin imaging system designed to visualize skin structure and vascular changes for clinical assessment and dermatological research. The company's system offers high-resolution three-dimensional imaging, deep tissue visualization, and fast non-invasive scanning, enabling dermatologists and academic skin researchers to accurately diagnose conditions and monitor skin health over time.

Contact Information

Formerly Known As
MDL Innovations
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Units 1&2 Maidstone Innovation Centre
  • Gidds Pond Way
  • Maidstone ME14 5FY
  • England, United Kingdom
+44 020
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Units 1&2 Maidstone Innovation Centre
  • Gidds Pond Way
  • Maidstone ME14 5FY
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VivoSight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC Completed Generating Revenue
12. Later Stage VC 25-Nov-2019 Completed Generating Revenue
11. Later Stage VC 21-Dec-2017 Completed Generating Revenue
10. Later Stage VC (Series C) 01-Oct-2015 Completed Generating Revenue
9. Later Stage VC (Series B) 16-Feb-2015 Completed Generating Revenue
8. Later Stage VC (Series A2) 13-Jan-2014 Completed Generating Revenue
7. Grant 01-Jan-2014 Completed Generating Revenue
6. Later Stage VC (Series A1) 15-Mar-2012 Completed Generating Revenue
5. Later Stage VC 17-Feb-2011 $3.69M $7.5M Completed Generating Revenue
4. Early Stage VC 08-Oct-2010 $1.23M $3.81M Completed Generating Revenue
To view VivoSight’s complete valuation and funding history, request access »

VivoSight Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A2 Ordinary
A1 Ordinary
A Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 7,799 $0.001641 $18.94 $18.94 1x $18.94 1.13%
Ordinary 15,000 $0.001641 $16.41 $16.41 1x $16.41 2.18%
To view VivoSight’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

VivoSight Patents

VivoSight Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4138697-A1 Treatment apparatus Pending 21-Apr-2020
EP-4138697-A4 Treatment apparatus Pending 21-Apr-2020
GB-202005820-D0 Treatment apparatus Inactive 21-Apr-2020
US-12502217-B2 Treatment apparatus Active 21-Apr-2020
US-20230149081-A1 Treatment apparatus Inactive 21-Apr-2020 A61B18/203
To view VivoSight’s complete patent history, request access »

VivoSight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VivoSight Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Plutus One Capital Venture Capital Minority
NCL Technology Ventures Venture Capital Minority
Origin Capital (UK) Venture Capital Minority
Kent Pension Fund Limited Partner Minority
Smith & Nephew Corporation Minority
You’re viewing 5 of 11 investors. Get the full list »

VivoSight FAQs

  • When was VivoSight founded?

    VivoSight was founded in 2006.

  • Where is VivoSight headquartered?

    VivoSight is headquartered in Maidstone, United Kingdom.

  • What is the size of VivoSight?

    VivoSight has 18 total employees.

  • What industry is VivoSight in?

    VivoSight’s primary industry is Diagnostic Equipment.

  • Is VivoSight a private or public company?

    VivoSight is a Private company.

  • What is VivoSight’s current revenue?

    The current revenue for VivoSight is .

  • How much funding has VivoSight raised over time?

    VivoSight has raised $20.8M.

  • Who are VivoSight’s investors?

    Plutus One Capital, NCL Technology Ventures, Origin Capital (UK), Kent Pension Fund, and Smith & Nephew are 5 of 11 investors who have invested in VivoSight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process